Jeffrey B. Landau

Insider Reports History

Location
South San Francisco, CA
Signature
/s/ Lloyd Rowland, as Attorney-in-Fact for Jeffrey B Landau
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Jeffrey B. Landau:

Company Role Class Num Shares Value Price $ Report Date Ownership
CytomX Therapeutics, Inc. Chief Business Officer Common Stock 119,056 $146,332 $1.23 20 Aug 2024 Direct
CytomX Therapeutics, Inc. Chief Business Officer Common Stock 4,500 $5,531 $1.23 20 Aug 2024 Fidelity Traditional IRA
CytomX Therapeutics, Inc. Chief Business Officer Common Stock 3,180 $3,909 $1.23 20 Aug 2024 Schwab ROTH IRA
CytomX Therapeutics, Inc. Chief Business Officer Performance Stock Units (PSUs) 0 $0 $1.23 20 Aug 2024 Direct
CytomX Therapeutics, Inc. Chief Business Officer Stock Option (Right to Buy) 140,000 18 Jan 2024 Direct

Insider Reports Filed by Jeffrey B. Landau

Symbol Company Period Transactions Value $ Form Type Role Filing Time
CTMX CytomX Therapeutics, Inc. 20 Aug 2024 3 -$5,139 4 Chief Business Officer 22 Aug 2024, 18:01
CTMX CytomX Therapeutics, Inc. 19 Mar 2024 1 -$13,685 4 Chief Business Officer 21 Mar 2024, 16:36
CTMX CytomX Therapeutics, Inc. 18 Jan 2024 3 $0 4 Chief Business Officer 19 Jan 2024, 20:40
CTMX CytomX Therapeutics, Inc. 20 Dec 2023 1 -$5,628 4 Chief Business Officer 22 Dec 2023, 16:12
CTMX CytomX Therapeutics, Inc. 17 Dec 2023 2 $0 4 Chief Business Officer 19 Dec 2023, 19:56
CTMX CytomX Therapeutics, Inc. 20 Sep 2023 2 -$5,356 4 Chief Business Officer 22 Sep 2023, 19:15
CTMX CytomX Therapeutics, Inc. 16 Mar 2023 1 -$2,923 4 Chief Financial Officer 20 Mar 2023, 18:43
CTMX CytomX Therapeutics, Inc. 02 Feb 2023 3 $0 4 Chief Business Officer 06 Feb 2023, 15:49
CTMX CytomX Therapeutics, Inc. 10 Aug 2022 2 $0 4 Chief Business Officer 12 Aug 2022, 17:00
CTMX CytomX Therapeutics, Inc. 19 Jul 2022 2 -$5,982 4 Chief Business Officer 21 Jul 2022, 16:11
CTMX CytomX Therapeutics, Inc. 23 Mar 2022 0 $0 3 Chief Business Officer 28 Mar 2022, 16:12